Dechra Pharmaceuticals PLC Director/PDMR Shareholding (9715Q)

TIDMDPH

RNS Number : 9715Q

Dechra Pharmaceuticals PLC

05 December 2016

5 December 2016

Dechra(R) Pharmaceuticals PLC

(Dechra or the Company)

Notification and public disclosure of transactions by

persons discharging managerial responsibilities (PDMRs)

Purchase of shares:

Dechra Pharmaceuticals PLC announces that on 2 December 2016, Tony Rice purchased the shares set out below.

 
    Name         Capacity        Shares        Sale       Total beneficial      Percentage 
                                Purchased      Price        shareholding         of issued 
                                             per share        following        share capital 
                                                          this announcement 
 Tony Rice    Director/PDMR      20,000      GBP12.47          40,000             0.043% 
 

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Form

 
 1.   Details of the Person Discharging Managerial 
       Responsibility ("PDMR")/person closely 
       associated with them ("PCA") 
---  ----------------------------------------------------------------- 
 a)   Name                           Tony Rice 
---  -----------------------------  ---------------------------------- 
 2.   Reason for the notification 
---  ----------------------------------------------------------------- 
 a)   Position/status                Director/PDMR 
---  -----------------------------  ---------------------------------- 
 b)   Initial notification/          Initial Notification 
       amendment 
---  -----------------------------  ---------------------------------- 
 3.   Details of the Issuer 
---  ----------------------------------------------------------------- 
 a)   Name                           Dechra Pharmaceuticals PLC 
---  -----------------------------  ---------------------------------- 
 b)   LEI code                       N/A 
---  -----------------------------  ---------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ----------------------------------------------------------------- 
 a)   Description                    Ordinary Shares of 1 pence 
       of the financial               each 
       instrument 
 
       Identification                 ISIN: GB0009633180 
       code 
---  -----------------------------  ---------------------------------- 
 b)   Nature of                      Partial sale of shares obtained 
       the transaction                under the Company's Long Term 
                                      Incentive Plan to satisfy 
                                      tax liability 
---  -----------------------------  ---------------------------------- 
 c)   Price(s) and                   Price(s)          Volume(s) 
       volumes(s) 
                                      GBP12.47          20,000 
---  -----------------------------  ----------------  ---------------- 
 d)        Aggregated 
            information 
             *    Aggregate volume     N/A 
 
 
             *    Price 
---  -----------------------------  ---------------------------------- 
 e)   Date of the                    2016.12.02 
       transaction 
---  -----------------------------  ---------------------------------- 
 f)   Place of the                   London Stock Exchange 
       transaction 
---  -----------------------------  ---------------------------------- 
 

For further information, please contact:

Suzana Cross, General Counsel and Company Secretary

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHAKPDKDBDDQBK

(END) Dow Jones Newswires

December 05, 2016 06:06 ET (11:06 GMT)